ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹9.31 Cr | ₹5.36 Cr | ₹5.43 Cr | ₹13 Cr | ₹11 Cr |
What is the latest Contingent Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹9.31 Cr |
Mar2024 | ₹5.36 Cr |
Mar2023 | ₹5.43 Cr |
Mar2022 | ₹13 Cr |
Mar2021 | ₹11 Cr |
How is Contingent Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹9.31 Cr | 73.70 | |
Mar2024 | ₹5.36 Cr | -1.40 | |
Mar2023 | ₹5.43 Cr | -58.47 | |
Mar2022 | ₹13 Cr | 15.98 | |
Mar2021 | ₹11 Cr | - |
Compare Contingent Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ADVANCED ENZYME TECHNOLOGIES | ₹4,031.2 Cr | 5.6% | 6.5% | -16% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,864.0 Cr | -4.3% | -3% | -0.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹168,811.0 Cr | -3.3% | -7.4% | 34.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,352.0 Cr | 1.4% | 10.1% | 17.9% | Stock Analytics | |
CIPLA | ₹121,260.0 Cr | -4.4% | -0.5% | 0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,786.0 Cr | -5.2% | -5.7% | -5.9% | Stock Analytics |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ADVANCED ENZYME TECHNOLOGIES | 5.6% |
6.5% |
-16% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses